Clinical Trials
6 trialsNCT06901622 2025-03-30
Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma
The First Affiliated Hospital of Zhengzhou University
Phase 2 Enrolling by invitation
NCT04299581 2025-02-27
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma
Fudan University
Phase 2 Recruiting
NCT05236699 2025-02-14
CCGLC-005
Tongji Hospital
Phase 2 Completed
NCT04454905 2023-04-19
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Sun Yat-sen University
Phase 2 Unknown
NCT05697237 2023-01-25
Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT04642664 2021-06-03
ACABC
Peking Union Medical College Hospital
Phase 2 Completed